Related Experiment Video
Updated: Jun 21, 2026
10:03
Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Factors determining heterogeneity in coronary collateral development: A clinical perspective
Pier D Lambiase1, Michael S Marber
1Department of Cardiology, Rayne Institute, St Thomas' Hospital, Lambeth Palace Road, London, United Kingdom.
Experimental and Clinical Cardiology
|August 4, 2009
Summary
Collateral vessel development is key to protecting against heart attacks and ischemia. Understanding patient differences in this process is vital for improving future therapies.
Area of Science:
- Cardiovascular research
- Molecular and cellular biology
- Clinical medicine
Background:
- Collateral vessels protect against myocardial infarction and ischemia.
- Current therapeutic strategies include angiogenic peptides, genes, and cell transplantation.
- Significant patient variability exists in collateral development.
Purpose of the Study:
- To examine factors influencing collateral development heterogeneity in patients.
- To integrate clinical evidence with molecular and cellular research.
- To discuss implications for future therapeutic strategies.
Main Methods:
- Review of clinical evidence.
- Integration of recent molecular and cellular studies.
- Examination of factors affecting collateral development.
Main Results:
- Heterogeneity in collateral development is observed among patients with similar coronary disease.
- Understanding these differences is crucial for therapeutic efficacy.
- Specific pharmacological agents and novel strategies are under investigation.
Conclusions:
- Factors contributing to variability in collateral development require further investigation.
- This understanding is essential for optimizing therapeutic interventions.
- Future research should focus on personalized approaches to enhance collateralization.
Related Concept Videos
01:26Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
01:30Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
01:30Coronary Artery Disease I: Introduction
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
01:30Acute Coronary Syndrome III: Diagnostic Studies
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
01:30Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...